Dabur India Ltd. News and Updates

Name: Latest research reports of Dabur India Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Dabur India Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news on Dabur India Ltd. from all sources in a single place.

Load latest

Dabur India Ltd.

28 May 2020

535.15

-0.10%

Dabur India

Buy: Dabur India Ltd.

Target

ICICI Securities Limited

With increasing health consciousness, some products with immunity booster proposition like Chyawanprash, Honey & OTC products are gaining traction. Further, the company also launched five new products in the healthcare space along with immunity booster kit. DIL posted 400% surge in Chyawanprash demand & 80% growth in honey in the last few months inducing it to expand capacity of these products to meet the current demand. We believe health supplement would be driving the growth and could see structural demand improvement given increasing consumer...

Dabur India Ltd. has an average target of 563.57 from 7 brokers.

Dabur India Ltd.

27 May 2020

535.15

-0.10%

Q4FY20 Result Update - Aggression in new launches positive; Hold

Hold: Dabur India Ltd.

Target

Prabhudas Lilladhar

with launch of a slew of immunity boosters, Juices and Milkshake and a new shampoo and Covid care products (Hand, Surface sanitizer, COVID kit and Veggies wash etc.), which will help neutralize the COVID impact to some extent. Dabur is positive on rural demand revival given large scale migration, however we believe that overall impact on demand would be negative given large scale erosion in pricing power. We estimate just 1.5% EPS growth in Fy21 and 10.7% CAGR over FY20-22. While the endeavor to drive growth and invest gains in business is positive, sustained momentum in new launches...

Dabur India Ltd. is trading above all available SMAs

Dabur India Ltd.

27 May 2020

535.15

-0.10%

Disappointing results, fair valuations limit upside

Neutral: Dabur India Ltd.

Target

Motilal Oswal

We also expect an impact on FY21 earnings owing to its high dependence on wholesales and on the profitable MENA business getting affected by the sharp crude price decline. sales/ EBITDA/ Adj. PAT grew 2%/ 3%/ margin contracted 260bp YoY to 18.9% (v/s est. The goal is to appeal to the millennial, increase accessibility and drive penetration through sampling and Management has identified power brands (1) together contribute ~65% of sales, but would contribute large part of Ad-spend focus on power brands would mean that even if overall ad spend rises by only ~6-7%, the increase in ad spends on power brands is likely to be in In its home and personal care portfolio where penetration is very high, the aim is to take market share from peers and plug gaps in terms of portfolio and Weak results and muted near-term outlook has led to 7.4%/9.0% decline in EPS forecasts for FY21/FY22E.

Dabur India Ltd. is trading above all available SMAs

Dabur India Ltd.

21 May 2020

535.15

-0.10%

Dabur chairman buys wellness startup stake

Economic Times

Dabur chairman buys wellness startup stakeNWNT, a bootstrapped startup set up by psychiatrist Sandeep Vohra in 2011, uses augmented human intelligence-based technology to screen, evaluate, prevent and treat emotional and mental health disorders.

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

05 May 2020

535.15

-0.10%

Dabur looks to sharpen its herbal edge as ayurvedic products get a push

Business Standard

As ayurvedic formulations get a renewed push in the fight against Covid-19, can one of the oldest player in the segment step up its game?

Dabur India Ltd. has an average target of 563.57 from 7 brokers.

Dabur India resumes production at all manufacturing locations

Moneycontrol | 05 May 2020

Dabur India Ltd.

20 Apr 2020

535.15

-0.10%

Consumer companies call on government for allowing manufacturing of essentials in red zones

Economic Times

Dabur India, maker of Real juice and Vatika shampoo, said while recent guidelines issued by the Ministry of Home Affairs will definitely help ease the situation, forced closure of some factories of suppliers have stalled manufacturing of essentials.

Dabur India Ltd. is trading above all available SMAs

Dabur India Ltd.

13 Apr 2020

535.15

-0.10%

Dabur adopts agile launch strategy for healthcare, hygiene products

Business Line

In the face of Covid-19, company advances launch dates of products

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Consumer biz could bounce back in 3 months

Economic Times | 13 Apr 2020

Dabur India Ltd.

07 Apr 2020

535.15

-0.10%

Dabur Group launches a slew of measures to fight Covid-19

Business Line

Dabur Group on Tuesday said it has rolled out Dabur Aashray insurance scheme for its frontline staff, who are not covered by any State or corporate

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur group commits Rs 21 cr in fight against COVID-19

Moneycontrol | 07 Apr 2020

Dabur India Ltd.

02 Mar 2020

535.15

-0.10%

'Breach of 11,000-mark is quite likely; Granules, Dabur among top buys'

Moneycontrol

Market participants believe that the supply side shock is likely to get converted to demand destruction or deferment further pushing the economic recovery